Michael Ryskin
Stock Analyst at B of A Securities
(1.47)
# 3,486
Out of 5,165 analysts
41
Total ratings
52%
Success rate
-2.59%
Average return
Main Sectors:
Stocks Rated by Michael Ryskin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RXRX Recursion Pharmaceuticals | Maintains: Neutral | $7 → $6 | $3.40 | +76.47% | 3 | Feb 26, 2026 | |
| ZTS Zoetis | Maintains: Neutral | $135 → $140 | $121.74 | +15.00% | 8 | Feb 13, 2026 | |
| SDGR Schrödinger | Upgrades: Buy | $24 | $12.51 | +91.85% | 3 | Dec 15, 2025 | |
| RVTY Revvity | Maintains: Buy | $110 → $99 | $88.51 | +11.85% | 1 | Sep 22, 2025 | |
| TEM Tempus AI | Maintains: Neutral | $68 → $70 | $50.72 | +38.01% | 6 | Jun 25, 2025 | |
| IDXX IDEXX Laboratories | Maintains: Neutral | $535 → $475 | $592.23 | -19.79% | 3 | Apr 21, 2025 | |
| MRVI Maravai LifeSciences Holdings | Maintains: Buy | $9 → $8 | $3.12 | +156.82% | 3 | Mar 3, 2025 | |
| ALGN Align Technology | Maintains: Underperform | $200 → $206 | $176.33 | +16.83% | 6 | Dec 13, 2024 | |
| GH Guardant Health | Maintains: Buy | $28 → $40 | $87.73 | -54.41% | 1 | Jul 18, 2024 | |
| ALIT Alight | Maintains: Buy | $10 → $9.5 | $0.79 | +1,105.12% | 1 | Jun 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $27 → $24 | $6.75 | +255.56% | 2 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $27 → $24 | $7.78 | +208.48% | 2 | Jul 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $17 → $10 | $2.67 | +274.53% | 2 | Nov 10, 2021 |
Recursion Pharmaceuticals
Feb 26, 2026
Maintains: Neutral
Price Target: $7 → $6
Current: $3.40
Upside: +76.47%
Zoetis
Feb 13, 2026
Maintains: Neutral
Price Target: $135 → $140
Current: $121.74
Upside: +15.00%
Schrödinger
Dec 15, 2025
Upgrades: Buy
Price Target: $24
Current: $12.51
Upside: +91.85%
Revvity
Sep 22, 2025
Maintains: Buy
Price Target: $110 → $99
Current: $88.51
Upside: +11.85%
Tempus AI
Jun 25, 2025
Maintains: Neutral
Price Target: $68 → $70
Current: $50.72
Upside: +38.01%
IDEXX Laboratories
Apr 21, 2025
Maintains: Neutral
Price Target: $535 → $475
Current: $592.23
Upside: -19.79%
Maravai LifeSciences Holdings
Mar 3, 2025
Maintains: Buy
Price Target: $9 → $8
Current: $3.12
Upside: +156.82%
Align Technology
Dec 13, 2024
Maintains: Underperform
Price Target: $200 → $206
Current: $176.33
Upside: +16.83%
Guardant Health
Jul 18, 2024
Maintains: Buy
Price Target: $28 → $40
Current: $87.73
Upside: -54.41%
Alight
Jun 25, 2024
Maintains: Buy
Price Target: $10 → $9.5
Current: $0.79
Upside: +1,105.12%
Aug 15, 2023
Maintains: Buy
Price Target: $27 → $24
Current: $6.75
Upside: +255.56%
Jul 31, 2023
Maintains: Buy
Price Target: $27 → $24
Current: $7.78
Upside: +208.48%
Nov 10, 2021
Downgrades: Underperform
Price Target: $17 → $10
Current: $2.67
Upside: +274.53%